
CAS 1346600-85-8
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
7 Produkte.
Zolpidem Related Compound A (N,N-Dimethyl-2-[7-methyl-2-p-tolylimidazo[1,2-a]pyridin-3-yl]acetamide)
CAS:Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormel:C19H21N3OFarbe und Form:Off-White PowderMolekulargewicht:307.16846Zolpidem EP Impurity A (Zolpidem USP Related Compound A)
CAS:Formel:C19H21N3OFarbe und Form:White To Off-White SolidMolekulargewicht:307.40N,N-Dimethyl-2-[7-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide
CAS:Kontrolliertes ProduktFormel:C19H21N3OFarbe und Form:NeatMolekulargewicht:307.395-Methyl Zolpidem
CAS:Kontrolliertes Produkt<p>Applications An impurity of Zolpidem (Z650000).<br></p>Formel:C19H21N3OFarbe und Form:NeatMolekulargewicht:307.395-Methyl Zolpidem
CAS:<p>5-Methyl Zolpidem is a zolpidem tartrate that is used for the treatment of insomnia and as a sedative. It is an intermediate in the synthesis of zolpidem tartrate, which is synthesized from 5-methyl-1-(4-methoxybenzoyl)-1H-benzo[d]imidazole with potassium t-butoxide. The synthesis starts with the conversion of 5-methyl-1-(4-methoxybenzoyl)-1H-benzo[d]imidazole to 1-(4'-methylphenyl) benzene by reaction with methyl iodide followed by hydrolysis of the ester group to form 1-(4'-methylphenyl) benzene. The next step involves a nucleophilic substitution reaction using potassium t-butoxide to produce 1-(4'-methylphenyl) benzene t-butoxide, followed by reaction with methanol</p>Formel:C19H21N3OReinheit:Min. 95%Farbe und Form:White/Off-White SolidMolekulargewicht:307.39 g/mol







